Editorial
Accepted on 31 Oct 2025
Editorial: Enhancing Therapeutic Strategies: A Focus on Pharmacovigilance in New Wave Antidepressants and Antipsychotics
in Psychopharmacology
Frontiers in Psychiatry
Type at least 3 characters
593 articles
Editorial
Accepted on 31 Oct 2025
Editorial: Women in Psychiatry 2024: Psychopharmacology
in Psychopharmacology
Frontiers in Psychiatry
Case Report
Accepted on 30 Oct 2025
Development of Persistent Genital Aroual Disorder (PGAD) Due to a Possible Combination of Medications
in Psychopharmacology
Frontiers in Psychiatry
- 178 views
Original Research
Accepted on 27 Oct 2025
Association of Tirzepatide and the Risk of Suicide in a Real-World Cohort
in Psychopharmacology
Frontiers in Psychiatry
- 315 views
Original Research
Published on 16 Oct 2025
Toward precision psychiatry: theoretical implications of bimodal response patterns to vasopressin V1b receptor inhibition in depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1645225
- 666 views
Brief Research Report
Published on 30 Sep 2025
Nefazodone shortage in the United States: analysis of drug switching and utilization
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1613275
- 2,777 views
Original Research
Published on 29 Sep 2025
Arrhythmic events pertinent with antidepressants: a Bayesian disproportional analysis mining the FDA Adverse Event Reporting System database
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1637471
- 1,845 views
Original Research
Published on 26 Sep 2025
Recreational MDMA use in Norway: results from an internet convenience sample
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1619676
- 2,732 views
Case Report
Published on 23 Sep 2025
A case report of seizure worsening after perampanel add-on to oxcarbazepine: possible role of metabolic interaction and pharmacogenetics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1621598
- 1,777 views
Systematic Review
Published on 22 Sep 2025
Reporting of harms in systematic reviews focused on naltrexone: a cross-sectional study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1597019
- 1,541 views
Perspective
Published on 22 Sep 2025
The collective lie in ketamine therapy: a call to realign clinical practice with neurobiology
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1610335
- 2,686 views
Original Research
Published on 17 Sep 2025
Changes in self-reported alcohol consumption at high and low consumption in the wake of the COVID-19 pandemic: a test of the polarization hypothesis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1516090
- 1,589 views
Original Research
Published on 12 Sep 2025
Medication adherence in obsessive-compulsive disorders and evaluation of effective adherence support strategies
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1642622
- 2,202 views
Correction
Published on 11 Sep 2025
Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1698185
- 1,263 views
Hypothesis and Theory
Published on 09 Sep 2025
A framework for safe estradiol modulation in male bipolar disorder: theoretical justification for SERM-enabled adjunctive therapy
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1644175
- 2,290 views
Clinical Trial
Published on 02 Sep 2025
Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1642025
- 2,467 views